SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Cancer, an astrological sign and alternate lifestyle!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hubert Few who wrote ()1/20/1997 8:48:00 PM
From: Nikole Wollerstein   of 162
 
ITHACA, N.Y., March 7 (Reuter) - Paracelsian Inc said studies showed company
drug PN27,1 effectively blocks the secretion of prostate-specific antigen and the
growth of prostate cancer cells.

The antigen is among the most widely used biochemical indicators of prostate canc

The studies were carried out at the Virginia Prostate Center, a joint program
sponsored by the Eastern Virginia Medical School and the Sentara Cancer
Institute.

PN27,1 is one of several pharmaceuticals that are being studied by Paracelsian for
their potential benefit for the treatment of cancer, acquired immune deficiency
syndrome and heart disease.

The drug was identified from Paracelsian"s core library of traditional Chinese
medicine extracts using signal transduction technology.

-- New York newsdesk, 212-859-1610
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext